One in four people taking popular weight loss drugs such as Ozempic, Wigoby and Munjaro found they were throwing more food into the trash after they started taking the drugs.
One in four people taking popular weight loss drugs such as Ozempic, Wigoby and Munjaro find they throw more food in the trash after starting the drug, according to a new study. Ta.
The survey results are Published in the scientific magazine “Nutrients”. highlighted the unintended consequences of drugs known as GLP-1 receptor agonists.
Researchers asked more than 500 current GLP-1 users across the U.S. a series of questions online, including, “Has your average daily calorie intake changed since you started taking it?”
Respondents were asked whether they agreed with the statement: “We are throwing away more of the food we buy.” According to the survey, 25% agreed and 61% disagreed.
“We found that the longer you’ve been on medication, the less likely you are to agree with that statement. This means you’re probably making some adjustments, rebalancing your purchases, and learning how to waste as little food as possible.” ” says Brian Roe, a professor of agricultural economics at Ohio State University.
Low led the team that conducted the study.
“This will have a huge impact not only on the health and medical sector, but also on the food and agricultural sectors,” he said.
As research points out, this drug has been shown to affect eating habits by decreasing appetite, slowing gastric emptying, and changing food preferences.
“The people who were really overspending were the ones who were suffering from nausea, which is a common side effect of these types of drugs,” Lo says. “This suggests that drug side effects can influence food consumption and waste patterns.”
According to the researchers, use of GLP-1 drugs is on the rise, with “approximately 12% of U.S. adults reporting having taken at least one dose and 6% reporting actively using them. , 59% of adults claim to have heard some symptoms or many other things about these drugs. ”
Another study earlier this year found that monthly use of GLP-1 drugs among young people aged 12 to 25 was also sharply increasing.
According to the report, the number of young people aged 12 to 25 using the drug increased from about 8,700 per month in 2020 to more than 60,000 per month in 2023, an increase of almost 600%.
The Associated Press contributed to this report.
Sign up here to get the latest news and daily headlines delivered to your email inbox.
© 2024 WTOP. All rights reserved. This website is not directed to users within the European Economic Area.
